Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) traded up 8.6% on Wednesday . The stock traded as high as $45.09 and last traded at $44.97. 711,930 shares traded hands during mid-day trading, a decline of 5% from the average session volume of 751,268 shares. The stock had previously closed at $41.40. Wall […]
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) traded up 8.6% on Wednesday . The stock traded as high as $45.09 and last traded at $44.97. 711,930 shares traded hands during mid-day trading, a decline of 5% from the average session volume of 751,268 shares. The stock had previously closed at $41.40. Wall […]
Seven Eight Capital LP increased its holdings in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 140.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 45,906 shares of the biopharmaceutical company’s stock after acquiring an additional 26,831 shares during the quarter. Seven […]
Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Raised to $111 00 at Canaccord Genuity Group dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Pier 88 Investment Partners LLC grew its stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 76.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,590 shares of the biopharmaceutical company’s stock after acquiring an additional 8,910 shares during the […]